DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $615,000 | -51.7% | 30,485 | -10.7% | 0.03% | -50.0% |
| Q2 2021 | $1,274,000 | +45.1% | 34,146 | -0.5% | 0.07% | +36.0% |
| Q1 2021 | $878,000 | +21.9% | 34,319 | +5.0% | 0.05% | -3.8% |
| Q4 2020 | $720,000 | -61.9% | 32,676 | -68.9% | 0.05% | -14.8% |
| Q3 2020 | $1,889,000 | +13.5% | 104,990 | +60.3% | 0.06% | +41.9% |
| Q2 2020 | $1,664,000 | +5.0% | 65,494 | -24.1% | 0.04% | +2.4% |
| Q1 2020 | $1,585,000 | -55.2% | 86,289 | -46.2% | 0.04% | -16.0% |
| Q4 2019 | $3,535,000 | +600.0% | 160,452 | +356.4% | 0.05% | +733.3% |
| Q3 2019 | $505,000 | – | 35,155 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $89,888,000 | 13.40% |
| EcoR1 Capital, LLC | 3,627,597 | $79,916,000 | 7.20% |
| Aquilo Capital Management, LLC | 614,436 | $13,536,000 | 5.08% |
| RTW INVESTMENTS, LP | 5,874,229 | $129,409,000 | 4.88% |
| BRIDGER MANAGEMENT, LLC | 1,981,633 | $43,655,000 | 3.15% |
| ACUTA CAPITAL PARTNERS, LLC | 387,500 | $8,537,000 | 2.11% |
| Integral Health Asset Management, LLC | 200,000 | $4,406,000 | 1.72% |
| Burrage Capital Management LLC | 104,047 | $2,292,000 | 1.54% |
| Parkman Healthcare Partners LLC | 240,000 | $5,287,000 | 1.53% |
| EAM Global Investors LLC | 122,237 | $2,693,000 | 1.08% |